03:59 PM EST, 02/06/2025 (MT Newswires) -- Health care stocks were lower late Thursday afternoon, with the NYSE Health Care Index down 0.8% and the Health Care Select Sector SPDR Fund (XLV) shedding 1%.

The iShares Biotechnology ETF (IBB) dropped 1.3%.

In corporate news, Eli Lilly ( LLY ) reported in-line Q4 sales on Thursday while reiterating 2025 revenue guidance that implies its top line will grow at the same pace as last year. Lilly shares rose 3.5%.

X4 Pharmaceuticals ( XFOR ) said Thursday that it is reducing its headcount by 43 employees, or about 30% of the workforce, ending research activities, and closing the Vienna, Austria facility. Its shares slumped past 7%.

Bausch + Lomb ( BLCO ) said a go-private deal with a third-party buyer won't materialize at this time. The deal was one of the options being explored to complete a full separation from Bausch Health ( BHC ) , it said. Bausch + Lomb ( BLCO ) shares fell 9.5%, and Bausch Health ( BHC ) was down past 10%.

Prestige Consumer Healthcare ( PBH ) shares jumped over 14% after its fiscal Q3 adjusted earnings and revenue came in ahead of analysts' estimates.